RadNet, Barnabas Health target business opportunities in N.J.

RadNet and Barnabas Health have formed a joint venture to pursue opportunities in diagnostic imaging and related businesses within New Jersey.

The joint venture was formed to achieve several objectives. First, the joint venture will establish a statewide diagnostic imaging network, and will contract exclusively on behalf of its imaging network with regional payors, including commercial insurance companies, utilization and radiology benefit managers, workers compensation carriers and other health plans and local insurers. The joint venture will initially have 37 patient access points across the state, and it intends to expand its access points through the acquisition of existing centers, development of new centers or through contracting with third-party imaging providers.

The joint venture also will provide management services to the existing RadNet and Barnabas imaging facilities in N.J. to include information technology, marketing, utilization review, billing and collecting, transcription, medical records management, equipment maintenance, purchasing and insurance.

Lastly, the joint venture was formed to pursue new business opportunities. These opportunities could include medical oncology, comprehensive breast disease management, teleradiology, information technology and clinical trials work.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.